US Stock MarketDetailed Quotes

ITRM Iterum Therapeutics

Watchlist
  • 1.0800
  • -0.0400-3.57%
Close Sep 6 16:00 ET
  • 1.1200
  • +0.0400+3.70%
Post 20:01 ET
24.52MMarket Cap-542P/E (TTM)

Iterum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Iterum Therapeutics Q2 2024 Earnings Date

Currency：USDAug 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.45
-0.28
+0.17
Beat Est.
+52.64%
+68.42%
+38.52%
Analyst Rating
Buy

Aug 31, 2024

Iterum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 13, 20242024/Q10.000 / 0.000--
Mar 28, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 13, 20242024/Q10.000 / 0.000--
Mar 28, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Iterum Therapeutics Earnings Reports

  • Iterum Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 19:34

  • Iterum Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 19:34

  • Iterum Therapeutics | 10-K: FY2023 Annual Report

    Mar 28 19:34

  • Iterum Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 20:30

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg